Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Genital Herpes

Treatments: Drug: Valaciclovir Hydrochloride.

Study type: Observational

Funder types: Industry

Identifiers

NCT01390805

112319

Details and patient eligibility

About

The purpose of this study is to collect and assess information on proper use of valaciclovir regarding safety and efficacy of long-term use in suppressive therapy for subjects with recurrent genital herpes.

Enrollment: 462 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who started suppressive therapy for recurrent genital herpes for the first time

Exclusion criteria

• Subjects with a history of hypersensitivity to the ingredients of VALTREX or aciclovir

Trial design

462 participants in 1 patient group

Subjects with recurrent genital herpes

Treatment:

Drug: Valaciclovir Hydrochloride.